Publication Name	World Journal of Clinical Urology
Manuscript ID	13106
Country	United Kingdom

Received	2014-08-06 08:40
Peer-Review Started	2014-08-06 18:20
To Make the First Decision	2014-09-28 12:27
Return for Revision	2014-09-29 14:39
Revised	2014-10-07 06:59
Second Decision	2015-05-04 19:19
Accepted by Journal Editor-in-Chief	2015-05-06 17:58
Accepted by Company Editor-in-Chief	2015-05-11 14:08
Articles in Press	2015-05-11 14:08
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-07-06 16:56
Publish the Manuscript Online	2015-08-04 11:03

ISSN	2219-2816 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Urology & Nephrology
Manuscript Type	Minireviews
Article Title	Update summarising the conclusions of the international consultation on male lower urinary tract symptoms
Manuscript Source	Invited Manuscript
All Author List	Altaf Mangera and Christopher Chapple
Funding Agency and Grant Number
Corresponding Author	Christopher Chapple, MD, Department of Urology Research, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2 JF, United Kingdom. c.r.chapple@shef.ac.uk
Key Words	International consultation; Antimuscarinic; Male lower urinary tract symptoms; Guidelines; Nocturia; Epidemiology; 5-α reductase; Phosphodiesterase-5 inhibitors; Alpha antagonist
Core Tip	Men with lower urinary tract symptoms (LUTS) should be assessed not only for symptom severity and bother but also for risk of progression. Men with a PSA > 1.4 or a prostate larger than 30 mL should be considered for therapy to reduce prostate volume. With the options for management of men with LUTS also involving antimuscarinics, B3 agonists, phosphodiesterase inhibitors and a plethora or surgical options, a personalised approach is required. This is intended will lead to greatest patient satisfaction and improvement in quality of life.
Publish Date	2015-08-04 11:03
Citation	Mangera A, Chapple C. Update summarising the conclusions of the international consultation on male lower urinary tract symptoms. World J Clin Urol 2015; 4(2): 83-91
URL	http://www.wjgnet.com/2219-2816/full/v4/i2/83.htm
DOI	http://dx.doi.org/10.5410/wjcu.v4.i2.83

Full Article (PDF)	WJCU-4-83.pdf
Full Article (Word)	WJCU-4-83.doc
Manuscript File	13106-Review.doc
Answering Reviewers	13106-Answering reviewers.pdf
Audio Core Tip	13106-Audio core tip.MP3
Conflict-of-Interest Disclosure Form	13106-Conflict-of-interest statement.pdf
Copyright License Agreement	13106-Copyright assignment.pdf
Peer-review Report	13106-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	13106-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	13106-Scientific misconduct check.pdf
Scientific Editor Work List	13106-Scientific editor work list.pdf